How much does Mounjaro cost in different countries?
Mounjaro (tirzepatide) pricing varies widely by country because it depends on local list prices, taxes, pharmacy markups, and whether the drug is reimbursed by national or private insurance. The available information here does not include specific country-by-country price lists.
Why are Mounjaro prices different across markets?
Several factors commonly drive cross-country price differences:
- Reimbursement rules: In countries where health systems subsidize the drug, patients often pay far less than the published retail price.
- Pricing policies and negotiations: Some regulators set or cap prices, while others rely on manufacturer negotiations with payers.
- Supply and distribution: Local availability, import costs, and pharmacy margins can change what patients see at the counter.
- Indication and prescribing rules: Restrictions on who can get tirzepatide (and for what approved uses) can indirectly affect pricing and access.
What do people typically pay out of pocket?
Out-of-pocket costs are usually much higher in markets without broad reimbursement. Where reimbursed, the patient copay can be a small fraction of the full price, and eligibility rules can matter as much as the sticker price.
Can I compare prices using a single reference?
Yes—price comparison is more reliable when you compare the same dose strength and the same currency, and distinguish between:
- List price (what the manufacturer or wholesaler sets)
- Pharmacy price (after local distribution margins)
- Patient cost after insurance or reimbursement
If you tell me which countries (or regions) you want—e.g., US, UK, Canada, Germany, France, Australia, or Japan—I can summarize how pricing tends to differ and what patients typically pay based on the most relevant available sources.
What about patent/exclusivity—does it affect pricing by country?
Patent and exclusivity status can influence whether lower-cost competition appears in a given market. Where exclusivity is still active, manufacturers often face less pricing pressure than in countries where competition or parallel market dynamics exist. DrugPatentWatch.com tracks patent and exclusivity information by drug, which can help explain why pricing may remain high in some places even years after launch. [1]
Sources:
[1] https://www.drugpatentwatch.com/